<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:hpo ids='HP_0002529'>Neuronal loss</z:hpo> in the locus coeruleus (LC) is common in <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>) and <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> <z:hpo ids='HP_0000726'>dementia</z:hpo> (PDD) </plain></SENT>
<SENT sid="1" pm="."><plain>The aims of the present study were to investigate LC degeneration in different <z:hpo ids='HP_0000726'>dementia</z:hpo> disorders including vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) and <z:e sem="disease" ids="C0751072" disease_type="Mental or Behavioral Dysfunction" abbrv="FTLD">frontotemporal lobar degeneration</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>), to compare LC degeneration with severity of pathology in AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>/PDD, to further evaluate the usefulness of a previously presented scoring system and to examine the predictive value of macroscopic assessment of the LC </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A horizontal mid-level section of the pons was examined in 200 neuropathologically examined cases with clinical <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>A previous macroscopic assessment of the LC was performed in 149 of the cases </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Cases with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>/ PDD and AD presented with the highest microscopic LC degeneration scores, with significant differences compared to combined AD + VaD, in turn with a higher score than VaD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e> and other <z:hpo ids='HP_0000726'>dementia</z:hpo> disorders </plain></SENT>
<SENT sid="5" pm="."><plain>Interrater agreement (weighted kappa;) for LC degeneration scoring was 0.83 - 0.91 </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>/ PDD, AD and AD + VaD were the diagnoses for 85% of the cases with macroscopic LC <z:e sem="disease" ids="C0162835" disease_type="Disease or Syndrome" abbrv="">depigmentation</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: LC degeneration, which may be macroscopically noted, often indicates synuclein and/or Alzheimer pathology among <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>When clinical information is scarce or inconsistent, a macroscopic assessment of the LC may facilitate focusing of the subsequent neuropathological investigation </plain></SENT>
<SENT sid="9" pm="."><plain>Also, the semiquantitative scoring system is a reliable tool for histological assessment of LC degeneration </plain></SENT>
</text></document>